Literature DB >> 6148110

Some normal and abnormal behavioral syndromes due to transmitter gating of opponent processes.

S Grossberg.   

Abstract

Opponent processes have long been known to be a basic building block of neural circuits. This article describes properties of opponent processes in which phasic cues and tonic arousal are gated by slowly accumulating chemical transmitters. These opponent processes are called gated dipoles. Gated dipole circuits exhibit syndromes of formal properties that can be used to support or dis-confirm their generative role in a complex body of behavioral data. A wide variety of normal and abnormal behavioral and physiological data exhibit properties analogous to those of gated dipole circuits. These include data about intracellular adaptation, habituation, and rebound; dishabituation and attentional reset by an unexpected event; inverted U properties due to underarousal or overarousal; juvenile hyperactivity; parkinsonism; hyperphagic eating; simple schizophrenia; actions of analgesic agents such as endorphins, electrical brain stimulation, and loud noise; tolerance-withdrawal symptoms, and a new approach to their prevention; normal and abnormal circadian rhythms, as in narcolepsy and manic-depressive psychosis; processing of reinforcing, drive, and motivating signals. Some data predictions derived from gated dipole circuits are also summarized.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6148110

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  14 in total

1.  Representations of appetitive and aversive information in the primate orbitofrontal cortex.

Authors:  Sara E Morrison; C Daniel Salzman
Journal:  Ann N Y Acad Sci       Date:  2011-12       Impact factor: 5.691

Review 2.  NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development.

Authors:  John H Krystal; D Cyril D'Souza; Daniel Mathalon; Edward Perry; Aysenil Belger; Ralph Hoffman
Journal:  Psychopharmacology (Berl)       Date:  2003-09-02       Impact factor: 4.530

Review 3.  Opponency revisited: competition and cooperation between dopamine and serotonin.

Authors:  Y-Lan Boureau; Peter Dayan
Journal:  Neuropsychopharmacology       Date:  2010-09-29       Impact factor: 7.853

4.  Expectation modulates neural responses to pleasant and aversive stimuli in primate amygdala.

Authors:  Marina A Belova; Joseph J Paton; Sara E Morrison; C Daniel Salzman
Journal:  Neuron       Date:  2007-09-20       Impact factor: 17.173

5.  Examining the underpinnings of loudness dependence of auditory evoked potentials with positron emission tomography.

Authors:  Rajapillai L I Pillai; Elizabeth A Bartlett; Mala R Ananth; Chencan Zhu; Jie Yang; Greg Hajcak; Ramin V Parsey; Christine DeLorenzo
Journal:  Neuroimage       Date:  2020-03-10       Impact factor: 6.556

6.  A neural model of basal ganglia-thalamocortical relations in normal and parkinsonian movement.

Authors:  J L Contreras-Vidal; G E Stelmach
Journal:  Biol Cybern       Date:  1995-10       Impact factor: 2.086

Review 7.  Acute and chronic effects of ketamine upon human memory: a review.

Authors:  Celia J A Morgan; H Valerie Curran
Journal:  Psychopharmacology (Berl)       Date:  2006-09-28       Impact factor: 4.530

Review 8.  Impaired Tuning of Neural Ensembles and the Pathophysiology of Schizophrenia: A Translational and Computational Neuroscience Perspective.

Authors:  John H Krystal; Alan Anticevic; Genevieve J Yang; George Dragoi; Naomi R Driesen; Xiao-Jing Wang; John D Murray
Journal:  Biol Psychiatry       Date:  2017-01-13       Impact factor: 13.382

9.  A neural network approach to the classification of autism.

Authors:  I L Cohen; V Sudhalter; D Landon-Jimenez; M Keogh
Journal:  J Autism Dev Disord       Date:  1993-09

10.  Bipolar oscillations between positive and negative mood states in a computational model of Basal Ganglia.

Authors:  Pragathi Priyadharsini Balasubramani; V Srinivasa Chakravarthy
Journal:  Cogn Neurodyn       Date:  2019-11-20       Impact factor: 5.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.